StockData
Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc. (ALZN) stock

ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 10, 2026Score 4/30
$1.02−0.02 (-1.92%)

Close on Nov 19, 2026Market cap $4.92MP/E –Yield –

Alzamend Neuro revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Alzamend Neuro

Alzamend Neuro has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Alzamend Neuro figures

See a number that looks wrong?